Graft function/survival

Clinical trials for Graft function/survival explained in plain language.

Never miss a new study

Get alerted when new Graft function/survival trials appear

Sign up with your email to follow new studies for Graft function/survival, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a B-Cell drug stop antibodies from attacking a new kidney?

Disease control Completed

After a kidney transplant, some people make new antibodies that target the donated organ and can lead to its failure. This trial tests whether rituximab, a drug that depletes B cells, can reduce those antibodies and help the kidney survive longer. Kidney transplant recipients who…

Matched conditions: GRAFT FUNCTION/SURVIVAL

Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Sep 26, 2026 00:00 UTC

Graft function/survival

Get alerted when new Graft function/survival trials appear

Can a B-Cell drug stop antibodies from attacking a new kidney?